Cvrx Inc (CVRX) Stock Price, Quote & News

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was...

Industry: Medical Devices

Sector: Healthcare

Phone: 763 416 2840

Fax: 763 416 2841

Website: www.cvrx.com

Address:

9201 West Broadway Avenue, Suite 650, Minneapolis, United States

commoncentsinvestor Aug. 27 at 12:43 PM

$CVRX We were honored to support Dr. Jeff Crawford, Carrie Stone, NP, and the team at Legacy Emanuel Medical Center in Portland, OR on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1959981265152602154

0 · Reply

commoncentsinvestor Aug. 25 at 1:25 PM

$CVRX We're proud to partner with Dr. Harsh Jain, Dr. Prajwal Deshmukh and the team at Mercy Hospital in Buffalo, NY on their first #Barostim implant. Thank you for offering a novel device therapy option to your patients to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1958255908175192146

0 · Reply

commoncentsinvestor Aug. 23 at 2:02 PM

$CVRX We were proud to partner with Drs. Marius Saines, Moinakhtar Lala, Mehran Khorsandi and Vasim Lala and the team at the Center for Advanced Cardiac and Vascular Interventions on their first hashtag#Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of hashtag#heartfailure. https://www.linkedin.com/posts/cvrx_barostim-heartfailure-activity-7363228479779196929-Zycu/

1 · Reply

commoncentsinvestor Aug. 23 at 1:57 PM

$CVRX At The Christ Hospital Health Network, we’re committed to giving patients the most advanced treatment options for the best possible quality of life. Our heart failure team, the most experienced in the region, offers innovative therapies, access to leading clinical trials, and personalized care for every patient. One of our newest options is Barostim™ Baroreflex Activation Therapy, a breakthrough device placed just under the skin near the collarbone, with no hardware in the heart or blood vessels. https://www.facebook.com/photo.php?fbid=1346657217031027&set=a.819181683111919&type=3

0 · Reply

OnyxInvestments Aug. 23 at 10:39 AM

$CVRX CVRx Inc is facing medical device adoption challenges and reimbursement hurdles

1 · Reply

MedDevice Aug. 21 at 2:31 PM

$CVRX clearly signaled a lot of tier 3 and 4 activity (whatever that truly means for a startup) knowing all these unknown centers first implants were going to get posted. Is this an advanced HF solution or a general cardiology play? Does management even know?

0 · Reply

commoncentsinvestor Aug. 20 at 4:52 PM

$CVRX The Dresden Heart Center has successfully implanted the 150th Barostimulator (BAT) – an innovative treatment that has already enabled 150 patients to enjoy a significantly improved quality of life. https://x.com/CVRx_Barostim/status/1950583883738595373

0 · Reply

commoncentsinvestor Aug. 19 at 2:17 PM

$CVRX We were proud to partner with Drs. Marius Saines, Moinakhtar Lala, Mehran Khorsandi and Vasim Lala and the team at the Center for Advanced Cardiac and Vascular Interventions on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1957462898470486430

0 · Reply

1111tu Aug. 18 at 5:15 PM

$CVRX Hey- first time I can remember in the past year that there aren’t sales positions open on the website.

1 · Reply

commoncentsinvestor Aug. 15 at 1:12 PM

$CVRX We were honored to support Dr. Brett Starr, Dr. John Morrison, Twilla Walker, NP, and the team at Frye Regional Medical Center in Hickory, NC on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1955996150835609826

1 · Reply

CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 4:05 PM EDT - 25 days ago

CVRx Reports Second Quarter 2025 Financial and Operating Results

Jul 29, 2025, 8:30 AM EDT - 4 weeks ago

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 16, 2025, 7:30 AM EDT - 6 weeks ago

CVRx Announces Positive News on Outpatient Payment for Barostim

Jul 2, 2025, 4:02 AM EDT - 2 months ago

CVRx: Sell-Off Ignores Its True Potential

May 28, 2025, 4:30 PM EDT - 3 months ago

CVRx to Present at the William Blair 45th Annual Growth Stock Conference

May 10, 2025, 3:51 PM EDT - 3 months ago

CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript

Apr 24, 2025, 4:30 PM EDT - 4 months ago

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

Apr 9, 2025, 8:45 AM EDT - 5 months ago

CVRx Inc: Overreaction Creates Buying Opportunity

Apr 8, 2025, 8:35 AM EDT - 5 months ago

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

GBX RPM

Apr 7, 2025, 4:05 PM EDT - 5 months ago

CVRx Reports Preliminary First Quarter 2025 Financial Results

Feb 12, 2025, 2:45 PM EST - 7 months ago

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

Feb 4, 2025, 11:00 PM EST - 7 months ago

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

Feb 4, 2025, 4:05 PM EST - 7 months ago

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Jan 21, 2025, 4:30 PM EST - 7 months ago

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

Dec 23, 2024, 4:30 PM EST - 8 months ago

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 10 months ago

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 6, 2024, 9:04 PM EST - 10 months ago

CVRx: Impressive Top-Line Growth Seems Priced In

Oct 29, 2024, 10:38 PM EDT - 10 months ago

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

Oct 18, 2024, 2:08 PM EDT - 11 months ago

CVRx announces new CPT® Category I codes for Barostim

Oct 15, 2024, 4:30 PM EDT - 11 months ago

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

Sep 3, 2024, 8:30 AM EDT - 1 year ago

CVRx Announces Appointment of Two New Board Members

Aug 19, 2024, 4:00 PM EDT - 1 year ago

CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Aug 19, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

Aug 18, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

Aug 17, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

Aug 16, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 15, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 14, 2024, 10:30 PM EDT - 1 year ago

CVRx Inc Shareholders Invited To Join Fraud Inquiry With The Schall Law Firm

Aug 14, 2024, 12:30 AM EDT - 1 year ago

CVRx Inc Investors May Participate In Fraud Investigation With The Schall Law Firm

Aug 13, 2024, 2:00 AM EDT - 1 year ago

CVRx Inc Investors Urged To Join The Fraud Investigation With The Schall Law Firm

Aug 9, 2024, 8:30 PM EDT - 1 year ago

CVRx Inc Investors Encouraged to Participate in Fraud Investigation With The Schall Law Firm

Aug 8, 2024, 4:00 PM EDT - 1 year ago

CVRx Inc Investors Can Join Fraud Investigation With The Schall Law Firm

Aug 7, 2024, 4:15 PM EDT - 1 year ago

CVRx Inc Investors Are Eligible To Join Fraud Investigation With The Schall Law Firm

Aug 6, 2024, 3:30 PM EDT - 1 year ago

CVRx Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

commoncentsinvestor Aug. 27 at 12:43 PM

0 · Reply

commoncentsinvestor Aug. 25 at 1:25 PM

0 · Reply

commoncentsinvestor Aug. 23 at 2:02 PM

1 · Reply

commoncentsinvestor Aug. 23 at 1:57 PM

0 · Reply

OnyxInvestments Aug. 23 at 10:39 AM

$CVRX CVRx Inc is facing medical device adoption challenges and reimbursement hurdles

1 · Reply

MedDevice Aug. 21 at 2:31 PM

0 · Reply

commoncentsinvestor Aug. 20 at 4:52 PM

0 · Reply

commoncentsinvestor Aug. 19 at 2:17 PM

$CVRX We were proud to partner with Drs. Marius Saines, Moinakhtar Lala, Mehran Khorsandi and Vasim Lala and the team at the Center for Advanced Cardiac and Vascular Interventions on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1957462898470486430

0 · Reply

1111tu Aug. 18 at 5:15 PM

$CVRX Hey- first time I can remember in the past year that there aren’t sales positions open on the website.

1 · Reply

commoncentsinvestor Aug. 15 at 1:12 PM

1 · Reply

commoncentsinvestor Aug. 10 at 11:45 PM

$CVRX Where We Take Research to Heart Putting your heart in someone else’s hands takes a leap of faith. We honor your trust in us with respect and reverence, using our latest research to bring you the best possible heart care. https://www.adventhealth.com/institute/cardiovascular/cardiovascular-research?listFilters=query%3Dbarostim%26cat%3Dglobal

1 · Reply

commoncentsinvestor Aug. 10 at 11:42 PM

$CVRX We're proud to partner with Dr. Charles Schwartz, Dr. Michele DeGregorio, and the team at Trinity Health Oakland Hospital on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1953916793212612856

2 · Reply

MedDevice Aug. 8 at 6:12 PM

$CVRX stock has not moved upward on positive earnings in over a year.

0 · Reply

MedDevice Aug. 7 at 1:07 PM

$CVRX Analysts are asking the wrong question. Why cant per center implants and Rev per center grow? "Dabblers" are not an adequate answer. Why the need to breakout an internal metric like Tier 3 and 4 centers? Just to justify an increase in active centers this quarter?

1 · Reply

JarvisFlow Aug. 5 at 12:30 PM

Cantor Fitzgerald updates rating for CVRx ( $CVRX ) to Overweight, target set at 11.

0 · Reply

MITornado Aug. 4 at 9:11 PM

$CVRX Good call. We’ll get there eventually. Slow and steady.

1 · Reply

1111tu Jul. 29 at 7:36 PM

$CVRX A decent summary. https://www.ainvest.com/news/cvrx-barostim-gains-traction-cms-reimbursement-policies-shift-gears-2507/

1 · Reply

commoncentsinvestor Jul. 29 at 12:41 PM

$CVRX We’re proud to partner with Dr. Russell Ronson, Dr. Sumit Verma and team at Baptist Hospital in Pensacola, FL on their first #Barostim implant. The Baptist Heart Failure "Optimization" team is the first site on the Gulf Coast to offer Barostim and is actively involved in offering innovative therapies to improve the lives of patients with #heartfailure. Thanks to Dr. Brent Videa, Dr. Brian Payne, Libby Berg, NP, Lesa Allen-Stanton, Angela Andersen, NP, Tina Lacsamana, NP, and Toinetta Coolie, NP, the team at Baptist Heart and Vascular. https://x.com/CVRx_Barostim/status/1949914946290192628

1 · Reply

1111tu Jul. 28 at 4:17 PM

$CVRX will it close the $9.10 gap before earnings?

1 · Reply

commoncentsinvestor Jul. 24 at 2:35 PM

$CVRX CVRx | Barostim Congratulations to Dr. Jeko Madjarov (Coastal Thoracic Surgical Associates), Dr. John Rommel and the team at @NovantHealth New Hanover Regional Medical Center on their 15th #Barostim implant! Thank you for advancing #heartfailure care by providing innovative therapy options to your patients. https://x.com/CVRx_Barostim/status/1948119548944675078

1 · Reply

commoncentsinvestor Jul. 23 at 4:44 PM

$CVRX CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025

1 · Reply

commoncentsinvestor Jul. 22 at 2:17 PM

$CVRX “$CVRX: The Most Underappreciated MedTech Play in Hypertension and Heart Failure” https://x.com/KapilSharmaMD/status/1947537798430642207

1 · Reply

Market Cap	197.71M
Revenue (ttm)	51.29M
Net Income (ttm)	-59.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-116.92%
Debt to Equity Ratio	0.85

Volume	116,900
Avg Vol	258,778
Day's Range	N/A - N/A
Shares Out	26.15M
Stochastic %K	81%
Beta	1.27
Analysts	Strong Sell
Price Target	$12.50